Comparison of cancer diagnoses between the US solid organ transplant registry and linked central cancer registries

E. L. Yanik, L. M. Nogueira, L. Koch, G. Copeland, C. F. Lynch, K. S. Pawlish, J. L. Finch, A. R. Kahn, B. Y. Hernandez, D. L. Segev, R. M. Pfeiffer, J. J. Snyder, B. L. Kasiske, E. A. Engels

Research output: Contribution to journalArticlepeer-review

30 Scopus citations


US transplant centers are required to report cancers in transplant recipients to the transplant network. The accuracy and completeness of these data, collected in the Scientific Registry of Transplant Recipients (SRTR), are unknown. We compared diagnoses in the SRTR and 15 linked cancer registries for colorectal, liver, lung, breast, prostate and kidney cancers; melanoma; and non-Hodgkin lymphoma (NHL). Among 187 384 transplants, 9323 cancers were documented in the SRTR or cancer registries. Only 36.8% of cancers were in both, with 47.5% and 15.7% of cases additionally documented solely in cancer registries or the SRTR, respectively. Agreement between the SRTR and cancer registries varied (kappa = 0.28 for liver cancer and kappa = 0.52–0.66 for lung, prostate, kidney, colorectum, and breast cancers). Upon evaluation, some NHLs documented only in cancer registries were identified in the SRTR as another type of posttransplant lymphoproliferative disorder. Some SRTR-only cases were explained by miscoding (colorectal cancer instead of anal cancer, metastases as lung or liver cancers) or missed matches with cancer registries, partly due to recipients’ outmigration from catchment areas. Estimated sensitivity for identifying cancer was 52.5% for the SRTR and 84.3% for cancer registries. In conclusion, SRTR cancer data are substantially incomplete, limiting their usefulness for surveillance and research.

Original languageEnglish (US)
Pages (from-to)2986-2993
Number of pages8
JournalAmerican Journal of Transplantation
Issue number10
StatePublished - Oct 1 2016

Bibliographical note

Funding Information:
This research was supported in part by the Intramural Research Program of the National Cancer Institute. The authors gratefully acknowledge the support and assistance provided by individuals at the Health Resources and Services Administration (Monica Lin), the SRTR (Ajay Israni and Paul Newkirk) and the following cancer registries: the states of California (Tina Clarke), Colorado, Connecticut (Lou Gonsalves), Georgia, Hawaii (Brenda Hernandez), Iowa, Illinois, Michigan, New Jersey (Xiaoling Niu), New York, North Carolina (Chandrika Rao), Texas, Utah (Janna Harrell), and the Seattle?Puget Sound area of Washington (Margaret Madeleine). We also thank analysts at Information Management Services for programming support (David Castenson, Matthew Chaloux, Michael Curry, and Ruth Parsons). The SRTR is currently operated under contract number HHSH250201500009C (Health Resources and Services Administration) by the Minneapolis Medical Research Foundation, Minneapolis, MN. Previously, the SRTR was managed under contracts HHSH250201000018C and HHSH234200537009C. The following cancer registries were supported by the Surveillance, Epidemiology, and End Results Program of the National Cancer Institute: California (contracts HHSN261201000036C, HHSN261201000035C and HHSN261201000034C); Connecticut (HHSN 261201000024C); Hawaii (HHSN261201000037C, N01-PC-35137 and N01-PC-35139); Iowa (HSN261201000032C and N01-PC-35143); New Jersey (HHSN261201300021I and N01-PC-2013-00021); Seattle?Puget Sound (N01-PC-35142); and Utah (HHSN2612013000171). The following cancer registries were supported by the National Program of Cancer Registries of the Centers for Disease Control and Prevention: California (agreement 1U58 DP000807-01), Colorado (U58 DP000848-04), Georgia (5U58DP003875-01), Illinois (5U58DP003883-03), Maryland (U58DP12-1205 3919-03), Michigan (5U58DP003921-03), New Jersey (5U58/ DP003931-02), New York (U58DP003879), North Carolina (U58DP00 0832), and Texas (5U58DP000824-04). Additional support was provided by the states of California, Colorado, Connecticut, Illinois, Iowa, Massachusetts (Massachusetts Cancer Prevention and Control Cooperative Agreement 5458DP003920), New Jersey, New York (including the Cancer Surveillance Improvement Initiative), Texas, Utah, and Washington, as well as the University of Utah and the Fred Hutchinson Cancer Research Center in Seattle, WA.


Dive into the research topics of 'Comparison of cancer diagnoses between the US solid organ transplant registry and linked central cancer registries'. Together they form a unique fingerprint.

Cite this